19-11575250-G-T
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001611.5(ACP5):c.738C>A(p.Tyr246*) variant causes a stop gained, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y246Y) has been classified as Likely benign.
Frequency
Consequence
NM_001611.5 stop_gained, splice_region
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001611.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACP5 | NM_001611.5 | MANE Select | c.738C>A | p.Tyr246* | stop_gained splice_region | Exon 5 of 5 | NP_001602.1 | ||
| ACP5 | NM_001111034.3 | c.738C>A | p.Tyr246* | stop_gained splice_region | Exon 6 of 6 | NP_001104504.1 | |||
| ACP5 | NM_001111035.3 | c.738C>A | p.Tyr246* | stop_gained splice_region | Exon 7 of 7 | NP_001104505.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACP5 | ENST00000648477.1 | MANE Select | c.738C>A | p.Tyr246* | stop_gained splice_region | Exon 5 of 5 | ENSP00000496973.1 | ||
| ACP5 | ENST00000218758.10 | TSL:1 | c.738C>A | p.Tyr246* | stop_gained splice_region | Exon 7 of 7 | ENSP00000218758.4 | ||
| ACP5 | ENST00000412435.7 | TSL:2 | c.738C>A | p.Tyr246* | stop_gained splice_region | Exon 6 of 6 | ENSP00000392374.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152138Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000122 AC: 3AN: 245856 AF XY: 0.00000748 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461334Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726924 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152138Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74308 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation, as the last 80 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; Has not been previously published as pathogenic or benign to our knowledge
Spondyloenchondrodysplasia with immune dysregulation Pathogenic:1
This sequence change creates a premature translational stop signal (p.Tyr246*) in the ACP5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 80 amino acid(s) of the ACP5 protein. This variant is present in population databases (rs761798208, gnomAD 0.009%). This variant has not been reported in the literature in individuals affected with ACP5-related conditions. ClinVar contains an entry for this variant (Variation ID: 533474). This variant disrupts a region of the ACP5 protein in which other variant(s) (p.Ser267*) have been determined to be pathogenic (PMID: 21217752). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at